HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio Bassi Selected Research

Pancreaticoduodenectomy

11/2022The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy.
11/2022Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
6/2022Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol.
1/2022Pancreatoduodenectomy in obese patients: surgery for nonmalignant tumors might be deferred.
1/2022Postoperative serum hyperamylasemia (POH) predicts additional morbidity after pancreatoduodenectomy: It is not all about pancreatic fistula.
1/2022High Values of Drain Fluid Epidermal Growth Factor and Transforming Growth Factor-Beta Are Associated with the Development of Pancreatic Fistula after Pancreatoduodenectomy.
1/2022The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy.
1/2022Pure biliary leak vs. pancreatic fistula associated: non-identical twins following pancreatoduodenectomy.
12/2021Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy.
11/2021The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio Bassi Research Topics

Disease

81Neoplasms (Cancer)
06/2022 - 07/2002
62Pancreatic Neoplasms (Pancreatic Cancer)
12/2022 - 07/2002
61Pancreatic Fistula (Pancreatic Fistulas)
11/2022 - 06/2005
55Adenocarcinoma
11/2022 - 07/2002
23Fistula
11/2022 - 11/2012
16Neoplasm Metastasis (Metastasis)
06/2022 - 07/2002
11Neoplasms, Cystic, Mucinous, and Serous
05/2022 - 07/2007
11Pancreatitis
04/2022 - 01/2002
9Hemorrhage
12/2022 - 03/2003
9Chronic Pancreatitis
12/2021 - 05/2004
8Infections
01/2022 - 01/2002
8Margins of Excision
03/2019 - 01/2008
7Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 02/2015
5Carcinogenesis
01/2021 - 07/2002
3Sepsis (Septicemia)
12/2022 - 01/2008
3Hyperamylasemia
04/2022 - 01/2021
3Cicatrix (Scar)
03/2022 - 01/2021
3Surgical Wound Infection
01/2022 - 11/2018
3Biliary Fistula
01/2021 - 06/2014
3Necrosis
11/2017 - 02/2015
3Pain (Aches)
09/2017 - 01/2008
3Pancreatic Diseases (Pancreatic Disease)
11/2015 - 02/2015
3Lymphatic Metastasis
12/2013 - 03/2013
2Residual Neoplasm
03/2022 - 01/2022
2Inflammation (Inflammations)
03/2022 - 11/2017
2Obesity
01/2022 - 01/2019
2Diabetes Mellitus
11/2021 - 05/2004
2Wounds and Injuries (Trauma)
01/2021 - 01/2017
2Disease Progression
10/2019 - 01/2018
2Abdominal Abscess
09/2019 - 06/2014
2Splenic Infarction
09/2019 - 03/2012
2Cysts
01/2019 - 09/2013
2Carcinoma (Carcinomatosis)
01/2019 - 01/2010
2Wound Infection (Wound Infections)
01/2018 - 01/2016
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 05/2014
2Cholangiocarcinoma
01/2017 - 07/2015
2Insulinoma
06/2010 - 07/2002

Drug/Important Bio-Agent (IBA)

13Biological ProductsIBA
01/2021 - 03/2006
9AmylasesFDA Link
01/2021 - 08/2007
8GemcitabineFDA Link
10/2020 - 09/2010
7Fluorouracil (Carac)FDA LinkGeneric
02/2021 - 10/2003
7Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2004
5Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2012
5Octreotide (Sandostatin)FDA LinkGeneric
10/2021 - 01/2004
5Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 01/2002
4AntigensIBA
12/2022 - 08/2007
4folfirinoxIBA
02/2021 - 10/2018
4Irinotecan (Camptosar)FDA LinkGeneric
02/2021 - 01/2020
4Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2021 - 01/2020
4Leucovorin (Folinic Acid)FDA Link
11/2020 - 09/2010
3AlbuminsIBA
12/2022 - 08/2010
3CarbohydratesIBA
12/2022 - 08/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2015
3CytokinesIBA
01/2022 - 01/2017
3Pregnenolone Carbonitrile (PCN)IBA
12/2021 - 01/2018
3Tumor Biomarkers (Tumor Markers)IBA
04/2021 - 11/2002
3InterleukinsIBA
01/2019 - 06/2014
3Messenger RNA (mRNA)IBA
03/2013 - 07/2002
2N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA
04/2022 - 01/2022
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 11/2015
2Edotreotide (SMT 487)IBA
01/2022 - 01/2017
2Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 01/2018
2N-acetyltalosaminuronic acid (NAT)IBA
11/2021 - 03/2018
2Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
06/2021 - 11/2008
2EnzymesIBA
05/2021 - 09/2010
2SteroidsIBA
01/2021 - 05/2014
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2020 - 01/2017
2MucinsIBA
01/2019 - 02/2010
2PolyestersIBA
10/2018 - 01/2016
2Kazal Pancreatic Trypsin InhibitorIBA
04/2018 - 09/2013
2Cell-Free Nucleic AcidsIBA
11/2016 - 02/2015
2Capsules (Microcapsules)IBA
10/2016 - 03/2007
2Cephalosporins (Cephalosporin Antibiotics)IBA
01/2016 - 01/2004
2RNA (Ribonucleic Acid)IBA
12/2013 - 09/2010
2ezrinIBA
12/2013 - 09/2013
2AutoantibodiesIBA
09/2013 - 09/2010

Therapy/Procedure

52Pancreaticoduodenectomy
11/2022 - 01/2006
50Pancreatectomy
09/2022 - 04/2007
20Drug Therapy (Chemotherapy)
06/2022 - 03/2004
19Therapeutics
12/2021 - 11/2002
17Neoadjuvant Therapy
12/2022 - 05/2012
13Radiofrequency Ablation
08/2022 - 07/2010
10Adjuvant Chemotherapy
11/2021 - 03/2004
9Length of Stay
12/2022 - 07/2007
7Radiotherapy
03/2022 - 01/2006
6Lymph Node Excision (Lymph Node Dissection)
06/2022 - 01/2014
4Operative Time
01/2022 - 01/2007
4Pancreaticojejunostomy
01/2021 - 04/2006
3Stents
01/2022 - 12/2016
3Chemoradiotherapy
02/2019 - 03/2004
3Splenectomy
01/2019 - 03/2012
3Sutures (Suture)
10/2018 - 01/2016
3Enteral Nutrition (Feeding, Tube)
10/2014 - 11/2010
3Adjuvant Chemoradiotherapy
06/2014 - 03/2004
3Cholecystectomy
10/2013 - 01/2002
3Conservative Treatment
03/2013 - 07/2007
2Operative Surgical Procedures
06/2022 - 11/2012
2Antibiotic Prophylaxis
06/2021 - 01/2016
2Palliative Care (Palliative Therapy)
01/2018 - 03/2006
2Aftercare (After-Treatment)
01/2008 - 09/2004